Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyungsin Kim

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Nature Communications|July 12, 2024
Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancerTaijin Lan, Sara Arastu, Jarrick Lam, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 22, 2022
Calcipotriol, a synthetic Vitamin D analog, promotes antitumor immunity via CD4+T-dependent CTL/NK cell activationHyungsin Kim, Jeongsoo Kim, Jason K Sa, et al.
Theranostics|January 4, 2021
Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant gliomaPhei Er Saw, Xiaoding Xu, Bo Ram Kang, et al.
EMBO Reports|December 21, 2016
Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibitionYoung Dong Yoo, Dae-Hee Lee, Hyunjoo Cha-Molstad, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Nature Communications|July 12, 2024
Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancerTaijin Lan, Sara Arastu, Jarrick Lam, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 22, 2022
Calcipotriol, a synthetic Vitamin D analog, promotes antitumor immunity via CD4+T-dependent CTL/NK cell activationHyungsin Kim, Jeongsoo Kim, Jason K Sa, et al.
Theranostics|January 4, 2021
Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant gliomaPhei Er Saw, Xiaoding Xu, Bo Ram Kang, et al.
EMBO Reports|December 21, 2016
Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibitionYoung Dong Yoo, Dae-Hee Lee, Hyunjoo Cha-Molstad, et al.
Pageof 2